PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FAG1T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,280
Award facts
- Contract value 100% obligated
- $12,279.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $12,279.88 on February 2, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. The delivery order represents a single task under this comprehensive pharmaceutical supply vehicle, which enables AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026.
AmerisourceBergen's parent company, Cencora, Inc., maintains a significant pharmaceutical and medical supply presence across federal government agencies, particularly serving the Department of Defense and Department of Veterans Affairs. The company is qualified to supply specialty medications, brand-name and generic drugs, vaccines, medical devices, and critical care materials through competitively awarded contracts. This particular delivery order reflects the ongoing utilization of the IDC vehicle to fulfill immediate pharmaceutical procurement needs for military treatment facilities and federal healthcare systems, consistent with DLA's strategy to leverage prime vendor agreements for efficient and cost-effective medical supply chain management.
Quick answers
Who was awarded contract SPE2D826FAG1T?
SPE2D826FAG1T was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on February 2, 2026.
How much is contract SPE2D826FAG1T worth?
The government has obligated $12,280 on SPE2D826FAG1T.
Is contract SPE2D826FAG1T an order under another contract?
Yes. SPE2D826FAG1T is a delivery order under SPE2DX22D0099, an indefinite delivery contract.
Was contract SPE2D826FAG1T competed?
The extent of competition for SPE2D826FAG1T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award